Annual Drug Patent Expirations for TYKERB
Tykerb is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has sixty-eight patent family members in thirty-one countries.
The generic ingredient in TYKERB is lapatinib ditosylate. One supplier is listed for this compound. Additional details are available on the lapatinib ditosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
